Physician

Zorawar Singh Noor, M.D., M.H.S.

According to 2025 Medicare claims, Zorawar Noor, M.D., M.H.S. (NPI: 1376802843) practices hematology/oncology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 92653-3115.

Noor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 756 traditional Medicare patients, billed 168,656 HCPCS/CPT codes, and received $3,869,498 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 845 prescription claims across 230 beneficiaries totaling $2,091,577 in drug costs, led by Ibrance (Palbociclib). DME data shows 38 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,493 to $3,869,498. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,049 to $2,091,577. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	35	122	$10,493
2016	94	229	$17,394
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	135	26,826	$585,261
2020	354	83,672	$1,658,450
2021	419	106,438	$1,858,235
2022	523	124,724	$2,670,500
2023	526	141,126	$3,358,389
2024	756	168,656	$3,869,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	14	37	$1,049
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	25	91	$216,281
2020	99	482	$751,865
2021	144	661	$1,151,023
2022	188	1,015	$1,621,870
2023	197	1,078	$2,306,926
2024	230	845	$2,091,577

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	65	$4,301
2021	N/R	64	$4,157
2022	N/R	49	$1,804
2023	N/R	37	$3,130
2024	N/R	38	$1,632

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	374	764	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	218	290	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	430	776	$13
36415	Insertion of needle into vein for collection of blood sample	187	424	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	162	669	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	19	532	$249,739
Lenalidomide	Lenalidomide	14	392	$236,314
Verzenio	Abemaciclib	13	364	$193,851
Abiraterone Acetate	Abiraterone Acetate	19	570	$71,912
Creon	Lipase/Protease/Amylase	15	455	$46,960

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$949
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$472
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	13	$210

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Zorawar Singh Noor, M.D., M.H.S.?

Tedicare shows public-source Medicare data for Zorawar Singh Noor, M.D., M.H.S. (NPI 1376802843), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zorawar Singh Noor, M.D., M.H.S. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Zorawar Singh Noor, M.D., M.H.S.?

Zorawar Singh Noor, M.D., M.H.S. is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1235107566) in the available physician profile data.

Does Zorawar Singh Noor, M.D., M.H.S. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.